Dare Bioscience Competitors and Similar CompaniesClear all

Dare Bioscience's competitors and similar companies include Greenwich LifeSciences, CNS Pharmaceuticals and NexImmune.

	Dare Bioscience Dare Bioscience (formerly Cerulean Pharma) develops nanotechnology-based therapeutics for treating oncology, cardiovascular, autoimmune and inflammatory diseases.	Greenwich LifeSciences Greenwich LifeSciences is a clinical-stage biopharmaceutical company.	CNS Pharmaceuticals CNS Pharmaceuticals is a pre-clinical stage biotechnology company specializing in the development of treatments for brain tumors.	NexImmune NexImmune is a biopharmaceutical company developing immunotherapy products based on the Artificial Immune Modulation nanotechnology platform.
Founding Date	Founding Date 2006	Founding Date 2006	Founding Date 2017	Founding Date 2011
Type	Type Public	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development nanotech oncology pharma	Tags Healthcare biotech life sciences oncology pharma therapy	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development nanotech oncology pharma
Locations	Locations San Diego, US HQ	Locations Stafford, US HQ	Locations Houston, US HQ	Locations Gaithersburg, US HQ
Employees	Employees 980% increase	Employees 433% increase	Employees 433% increase	Employees 5032% decrease
Valuation ($)	Valuation ($) 33.8 m	Valuation ($) 186 m	Valuation ($) 4.7 m	Valuation ($) 372.4 k
Financial
Net income	Net income ($13.4m) (FY, 2025)	Net income ($15.8m) (FY, 2024)	Net income ($15.9m) (FY, 2025)	Net income ($32.3m) (FY, 2023)
Funding
Total funding raised	Total funding raised $ 115.7m	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 33.8m